Second International Conference on Clinical Metagenomics (ICCMg2): 19-20 October 2017, Switzerland
Metagenomics, based on next-generation sequencing (NGS), has been available for a decade and is now widely used for research purposes. In parallel, clinicians are currently paying a growing interest in how NGS could help in the diagnosis and management of several diseases.
The Second International Conference on Clinical Metagenomics (ICCMg2) welcomes participants to join this conference to share recent developments on clinical metagenomics from a broad perspective: infectious diseases, antimicrobial resistance, bio-informatics and microbiota.
There is a high quality program with keynotes given by the current leaders in clinical metagenomics.